Light at the end of the tunnel? new trial tests bright light for bipolar depression
NCT ID NCT05357313
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether sitting under a bright light for 30 minutes each day for six weeks can improve mood in people with bipolar depression who also tend to be evening types. Seventy adults will be randomly assigned to either the bright light or a placebo device. The goal is to see if this simple, drug-free approach can reduce depressive symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bright light therapy
- What this could lead to
- If it works, this could offer a simple, drug-free way to ease depression in people with bipolar disorder who tend to be night owls.
- What could go wrong
- This is a small, early-stage trial with only 70 people. The placebo effect is strong in depression studies, and results may not apply to everyone with bipolar disorder.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Chinese University of Hong Kong
Hong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single psychedelic dose rewire the depressed brain?
- Can brain implants read and treat bipolar depression without triggering mania?
- Brain wave patterns and inflammation: a clue to ECT's effectiveness in older adults?
- Could a common antibiotic and supplement lift bipolar depression?
- Could a new pill ease bipolar depression in young people?
- Can a blood test predict who will respond to ketamine for depression?